Browse > Article

Drug Interaction between Flavone and Paclitaxel in Rats  

최준식 (조선대학교 약학대학)
이진환 (조선대학교 약학대학)
Publication Information
YAKHAK HOEJI / v.47, no.2, 2003 , pp. 98-103 More about this Journal
Abstract
The purpose of this study was to investigate the effect of flavone (20 mg/kg) on the pharmacokinetic parameters and the bioavailability of paclitaxel (40 mg/kg) orally coadministered in rats. The plasma concentration of paclitaxel in combination with flavone was increased significantly (coadministration p＜0.05, pretreatment p＜0.0l) compared to that of control. Area under the plasma concentration-time curve (AVC) of paclitaxel with flavone was significantly (coadministration p＜0.05, pretreatment p＜0.0l) higher than that of control. Peak concentration (Cmax) of paclitaxel with flavone were significantly increased (coadministration p＜0.05, pretreatment p＜0.01) compared to that of control. Time to peak concentration (Tmax) of paclitaxel with flavone decreased significantly (p＜0.05) than that of control. The total body clearance (CLt) and elimination rate constant ($\beta$) of paclitaxel with flavone were significantly reduced (p＜0.05) compared to those of control. Half-life (t$_{1}$2/) of paclitaxel with flavone was significantly prolonged (p＜0.05) compared to that of control. Based on these results, it might be concluded that flavone may enhance bioavailability of paclitaxel through the inhibition of cytochrome P450 and P-glycoprotein, which are engaged in paclitaxel absorption and metabolism in liver and gastrogintestinal mucosa, respectively.
Keywords
Paclitaxel; pharmacokinetics; flavone; drug interaction; P-glycoprotein;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Effect of the grapfruit flavonoid naringen on pharmaco-kinetics of quinine in rats /
[ Zhang, H.;Wong, C. W.;Coville, P. G.;Wanwimolruk, S. ] / Drug Metabol Drug Interact
2 Determination of new anticancer drug, paclitaxel, in biological fluids by high performance liquid chromatography /
[ Mase, H.;Hiraoka, M.;Suzuki, F. ] / Yakugaku. Zasshi.   DOI
3 a class of modulators with bifunctional interactions at vicinal ATP-and steroid binding sites on mouse P-glycorotein /
[ Conseil, G.;Baubichon-cortary, H.;Dayan, G.;Jault, J. M.;Barron, D.;dI Pietro, A. ] / Proc. Natl. Acad. Sci.   DOI   ScienceOn
4 Structure-activity relationship for xenobiotic transport substrates and inhibitory ligands of p-glycoprotein /
[ Bain, L. J.;McLanchlan, J. B.;LeBanc, G. A. ] / Enviromental Health Perspectives   DOI   ScienceOn
5 Variability in human cytochrome P450 paclitaxel metabolism /
[ Sonnichsen, D. S.;Liu, Q.;Schuetz, E. G.;Schuetz, J. D.;Pappo, A.;Relling, M. V. ] / J. Pharmacol. Exp. Ther.
6 Plant flavoniods in biology and medicine /
[ Cody, V.(ed.) ] / Prog Clin Biol Res.
7 A pharmacokinetics analysis program for microcomputer /
[ Yamaoka, K.;Tanigawara, Y.;Nakagawa, T.;Uno, T. ] / J. Pham. Dyn.
8 Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells /
[ Ikegawa, T.;Ohtani, H.;Koyabu, N.;Juichi, M.;Iwase, Y.;Ito, C.;Furukawa, H.;Naito, M.;Tsuruo, T.;Sawada, Y. ] / Cancer Lett.   DOI   ScienceOn
9 The effects of the bioflavoniod quercetin on squamuscell carcinoma of head and neck origin /
[ Castilllo, M. H.;Perkins, E.;Campbell, J. H.(et al.) ] / Am J Surg.   DOI   ScienceOn
10 Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity /
[ Mathew, A. E.;Mejillano, M. R.;Nath, J. P.;Himes, R. H.;Stella, V. J. ] / J. Med. Chem.   DOI
11 Bioflavoniods : selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1 /
[ Doostdar, H.;Burke, M. D.;Mayer, R. T. ] / Toxicology   DOI
12 Assay of paclitaxel (Taxol) in plasma and urine by High Performance Liquid Chromatography /
[ Manrin, N.;Catalin, J.;Blachon, M. F.;Durand, A. ] / J. Chromato B.   DOI
13 Selective biotransformation of taxol to 6α-hydroxytaxol by human cytochrome P450 2C8 /
[ Rahman, A.;Korzekwa, K. R.;Grogan, J.;Gonzalez, F. J.;Harris, J. W. ] / Cancer Res.
14 Selective biotransformation of taxol to 6α-hydroxytaxol by human cytochrome P450 2C8 /
[ Rahman, A.;Korzekwa, K. R.;Grogan, J.;Gonzalez, F. J.;Harris, J. W. ] / Cancer Res.
15 Short communication; Taxol metabolism in rat hepatocytes /
[ Walle, T. ] / Biochem. Pharmacol.   DOI   ScienceOn
16 Metabolism of taxol by human hepatic microsomes and liver slices : participation of cytochrome P450 3A4 and an unknown P450 enzyme /
[ Harris, J. W.;Rahman, A.;Kim, B. R.;Guengerich, F. P.;Collins, J. M. ] / Cancer Res.
17 Clinical studies with modulators of multidrug resistance /
[ Fisher, G. A.;Sikic, B. I. ] / Hematol. Oncol. Clin. North Am.
18 Reversal of multidrug resistance by lipophilic drugs /
[ Hofsli, E.;Meyer, J. N. ] / Cancer Res.
19 Cytochrome P450 3A-mediated human liver microsomal taxol 6α-hydroxylation /
[ Kumar, G. N.;Walle, U. K.;Walle, T. ] / J. Pharmacol. Exp. Ther.
20 Effect of flavonols on P-glycoprotein activety in cultured rat hepatocytes /
[ Choi, C. H.;Romiti, N.;Cervelli, F.;Tongiani, R. ] / Life Sciences   DOI   ScienceOn
21 Inhibitory effect of quercetin on OVCA 433 cells and presence of type Ⅱ estrogen binding sites in primary ovarian tumours and cultured cells /
[ Scambia, G.;Ranelletti, F. O.;Benedetti Panici, P.(et al.) ] / Br J Cancer   DOI   ScienceOn
22 Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells /
[ Chaudhary, P. M.;Robinson, I. B. ] / Cell   DOI   ScienceOn
23 Taxol metabolism by human liver microsomes : identification of cytochrome P450 isozymes involved in its biotransformation /
[ Cresteil, T.;Monsarrat, B.;Alvinerid, P.;Treluyer, J. M.;Vieira, I.;Wright, M. ] / Cancer Res.
24 Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines /
[ Kutz, B. S.;Wellzel, U.;Daniel, H. ] / Eur. J. Nutr.   DOI   ScienceOn
25 Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line : P-glycoprotein as a possible target /
[ Soambia, G.;Ranelletti, F. O.;Panici, P. B.;Vincenzo, De R.;Bonanno, G.;Frrandina, G.;Piantelli, M.;Bussa, S.;Rumi, C.;Ciantriglia, M.(et al.) ] / Cancer Chemother Pharmacol.   DOI   ScienceOn
26 The biochemistry of P-glycoprotein-mediated multidrug resistance /
[ Endicott, J. A.;Ling, V. ] / Annu. Rev. Biochem.   DOI   ScienceOn
27 Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target /
[ Soambia, G.;Ranelletti, F. O.;Panici, P. B.;Vincenzo, De R.;Bonanno, G.;Frrandina, G.;Piantelli, M.;Bussa, S.;Rumi, C.;Ciantriglia, M.(et al.) ] / Cancer Chemother Pharmacol.   DOI   ScienceOn
28 influence of flavonoids on cell cycle pahse as analyzed by flowcytometry /
[ Koide, T.;Kamei, H.;Hashimoto, Y.;Kojima, T.;Terabe, K.;Umeda, T. ] / Cancer Biother Badiopharm.   DOI   ScienceOn
29 Clinical Pharmaco-kinetics of Paclitaxel /
[ Sonnichsen, D. S.;Relling, M. V. ] / Clin. Pharmacokinet.   DOI   ScienceOn
30 Plant flavoniods in biology and medicine /
[ Cody, V.(ed.) ] / Prog Clin Biol Res.
31 Growth-inhibitory effect of quercetin and presence of type Ⅱ estrogen binding sites in primary human transitional cell carcinomas /
[ Larocca, L. M.;Giustacchini, M.;Maggiano, N.(et al.) ] / J Urol.   DOI